British Pharmaceutical company GlaxoSmithKline announced a partnership with Canadian biopharmaceutical company Medicago plans to develop and evaluate a new vaccine against COVID-19.
New COVID-19 Vaccine Announced in GSK, Medicago Partnership

British Pharmaceutical company GlaxoSmithKline announced a partnership with Canadian biopharmaceutical company Medicago plans to develop and evaluate a new vaccine against COVID-19.